BiVictriX Therapeutics.
37 announcements.
37 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 11-09-2024 | BVX | BiVictriX Therapeutics | Cancellation - BiVictriX Therapeutics plc |
| 11:04 | 10-09-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 07:00 | 10-09-2024 | BVX | BiVictriX Therapeutics | Last Day of Dealings |
| 07:00 | 09-09-2024 | BVX | BiVictriX Therapeutics | Positive In Vivo Data from BVX002 Programme |
| 17:04 | 02-09-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 08:50 | 02-09-2024 | BVX | BiVictriX Therapeutics | Director Dealing |
| 17:05 | 29-08-2024 | BVX | BiVictriX Therapeutics | Result of General Meeting |
| 10:12 | 28-08-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 10:14 | 28-08-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 07:00 | 19-08-2024 | BVX | BiVictriX Therapeutics | TR-1: Notification of major holdings |
| 07:00 | 13-08-2024 | BVX | BiVictriX Therapeutics | Grant of Options |
| 07:00 | 12-08-2024 | BVX | BiVictriX Therapeutics | Proposed Voluntary Delisting |
| 07:00 | 01-08-2024 | BVX | BiVictriX Therapeutics | Interim Results |
| 17:00 | 24-07-2024 | BVX | BiVictriX Therapeutics | Result of Annual General Meeting |
| 07:00 | 26-06-2024 | BVX | BiVictriX Therapeutics | Publication of 2023 Annual Report & Notice of AGM |
| 07:00 | 13-06-2024 | BVX | BiVictriX Therapeutics | Compelling Safety Profile of BVX001 |
| 07:00 | 06-06-2024 | BVX | BiVictriX Therapeutics | Innovate UK Grant Award to Accelerate ADC Pipeline |
| 08:44 | 31-05-2024 | BVX | BiVictriX Therapeutics | BiVictriX – Full Year Results 2023 |
| 07:00 | 28-03-2024 | BVX | BiVictriX Therapeutics | Grant of Options – PDMR/Director Dealings |
| 12:30 | 04-01-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 12:30 | 04-01-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 07:00 | 04-01-2024 | BVX | BiVictriX Therapeutics | BiVictriX Hosts Inaugural Roundtable Discussion |
| 11:08 | 05-12-2023 | BVX | BiVictriX Therapeutics | Board Change |
| 07:00 | 30-11-2023 | BVX | BiVictriX Therapeutics | Pipeline update on BVX002 |
| 17:14 | 22-11-2023 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 07:00 | 15-11-2023 | BVX | BiVictriX Therapeutics | Patent Granted in Japan |
| 07:00 | 12-10-2023 | BVX | BiVictriX Therapeutics | Extended Survival Rates Reported with BVX001 |
| 07:00 | 03-10-2023 | BVX | BiVictriX Therapeutics | Appointment of Adrian Howd as CFO and CBO |
| 07:00 | 19-09-2023 | BVX | BiVictriX Therapeutics | Interim Results |
| 07:00 | 31-08-2023 | BVX | BiVictriX Therapeutics | Total Voting Rights |
| 07:00 | 17-08-2023 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 16:17 | 11-08-2023 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 17:18 | 08-08-2023 | BVX | BiVictriX Therapeutics | Result of General Meeting |
| 12:31 | 19-07-2023 | BVX | BiVictriX Therapeutics | Proposed Fundraise in excess of £2 million |
| 07:00 | 17-07-2023 | BVX | BiVictriX Therapeutics | Positive final data in preclinical efficacy study |
| 07:00 | 19-06-2023 | BVX | BiVictriX Therapeutics | Positive interim data |
| 07:00 | 06-06-2023 | BVX | BiVictriX Therapeutics | BiVictriX nominates clinical candidate for BVX001 |